Patient-Reported Outcomes in Lupus

Patient-reported outcome (PRO) was identified as a core systemic lupus erythematosus (SLE) outcome in 1999. More than 20  years later, however, generic PRO measures evaluating impact in SLE are used mainly for research. Generic and disease-targeted PRO tools have unique advantages. Significant progress in identification of patient disease–relevant PRO concepts and development of new PRO tools for SLE has occurred o ver the past 20 years. Further research needs to focus on responsiveness and minimally important differences of existing, promising PRO tools to facilitate their use in SLE patient care and research.

Source: Rheumatic Disease Clinics of North America - June 15, 2021 Category: Rheumatology Authors: Narender Annapureddy, Meenakshi Jolly Source Type: research